BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Goosehead Insurance
GSHD
$2.29B
| $33.1M | ﹤0.01% |
781,590
+49,638
| +7% | +$2.2M |
|
2602
Camping World
CWH
$635M
| $33.1M | ﹤0.01% |
2,244,748
+56,555
| +3% | +$640K |
|
|
CHNG
2603
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $33.1M | ﹤0.01% |
2,017,540
+136,889
| +7% | +$1.84M |
|
|
BELFB
2604
Bel Fuse Inc Class B
BELFB
$4.1B
| $33M | ﹤0.01% |
1,608,073
+62,337
| +4% | +$1.02M |
|
|
GTS
2605
DELISTED
Triple-S Management Corporation
GTS
| $32.9M | ﹤0.01% |
1,780,019
-8,153
| -0.5% | -$139K |
|
2606
Quince Therapeutics
QNCX
$30M
| $32.9M | ﹤0.01% |
2,928
+2,151
| +277% | +$13M |
|
2607
XBiotech
XBIT
$69.5M
| $32.7M | ﹤0.01% |
1,751,921
+483,022
| +38% | +$6.22M |
|
|
KE
2608
Kimball Electronics
KE
$605M
| $32.7M | ﹤0.01% |
1,860,740
+3,343
| +0.2% | +$55K |
|
|
HTB
2609
HomeTrust Bancshares
HTB
$826M
| $32.7M | ﹤0.01% |
1,217,147
+63,885
| +6% | +$1.68M |
|
2610
Genesis Energy
GEL
$1.9B
| $32.5M | ﹤0.01% |
1,587,556
+48,162
| +3% | +$970K |
|
2611
Byline Bancorp
BY
$1.75B
| $32.4M | ﹤0.01% |
1,654,332
+191,538
| +13% | +$3.5M |
|
|
QTS.PRB
2612
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
| $32.2M | ﹤0.01% |
249,283
-24,166
| -9% | -$3.03M |
|
|
LVGO
2613
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $32.1M | ﹤0.01% |
1,280,004
+50,584
| +4% | +$1.21M |
|
2614
CALL
VanEck Semiconductor ETF
SMH
$70.1B
| $32M | ﹤0.01% |
+453,000
| New | +$29.7M |
|
2615
First Mid Bancshares
FMBH
$1.36B
| $32M | ﹤0.01% |
906,840
+60,002
| +7% | +$2.1M |
|
2616
Tucows
TCX
$142M
| $32M | ﹤0.01% |
517,292
-154
| -0% | -$8.78K |
|
2617
CALL
Johnson & Johnson
JNJ
$631B
| $31.9M | ﹤0.01% |
+218,900
| New | +$29.7M |
|
2618
GrafTech
EAF
$205M
| $31.9M | ﹤0.01% |
274,671
+998
| +0.4% | +$125K |
|
2619
argenx
ARGX
$54.2B
| $31.9M | ﹤0.01% |
198,808
-13,074
| -6% | -$1.77M |
|
2620
Ardelyx
ARDX
$997M
| $31.8M | ﹤0.01% |
4,242,362
+537,511
| +15% | +$3.27M |
|
2621
Bristow Group
VTOL
$1.38B
| $31.8M | ﹤0.01% |
1,564,218
+90,887
| +6% | +$1.8M |
|
|
ALTA
2622
DELISTED
Altabancorp
ALTA
| $31.8M | ﹤0.01% |
1,054,785
+53,281
| +5% | +$1.56M |
|
2623
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
| $31.7M | ﹤0.01% |
1,058,462
+573,941
| +118% | +$17.2M |
|
|
CPRX
2624
DELISTED
Catalyst Pharmaceutical
CPRX
| $31.7M | ﹤0.01% |
8,444,965
+189,943
| +2% | +$888K |
|
|
TLRD
2625
DELISTED
Tailored Brands, Inc.
TLRD
| $31.7M | ﹤0.01% |
7,646,828
+10,942
| +0.1% | +$51.5K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.